TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 243 filers reported holding TG THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $7,599,000 | -42.2% | 399,949 | +1.3% | 1.14% | +4.7% |
| Q3 2021 | $13,144,000 | -18.3% | 394,949 | -4.8% | 1.09% | -16.1% |
| Q2 2021 | $16,096,000 | -35.0% | 414,949 | -19.2% | 1.30% | -30.6% |
| Q1 2021 | $24,758,000 | +130.4% | 513,649 | +148.7% | 1.88% | +148.0% |
| Q4 2020 | $10,745,000 | +803.7% | 206,549 | +105.8% | 0.76% | +394.8% |
| Q3 2017 | $1,189,000 | +45.5% | 100,366 | +23.5% | 0.15% | +71.9% |
| Q2 2017 | $817,000 | -49.0% | 81,266 | -40.9% | 0.09% | -52.4% |
| Q1 2017 | $1,602,000 | -87.6% | 137,500 | -91.0% | 0.19% | -70.2% |
| Q1 2016 | $12,965,000 | -28.6% | 1,521,667 | 0.0% | 0.63% | -19.0% |
| Q4 2015 | $18,153,000 | +23.0% | 1,521,667 | +3.9% | 0.77% | +14.5% |
| Q3 2015 | $14,758,000 | +15.2% | 1,464,105 | +89.6% | 0.68% | +26.6% |
| Q2 2015 | $12,808,000 | +89.7% | 772,017 | +77.0% | 0.53% | +108.6% |
| Q1 2015 | $6,751,000 | – | 436,084 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 8,198,337 | $33,613,000 | 1.96% |
| GREAT POINT PARTNERS LLC | 3,000,000 | $12,300,000 | 1.56% |
| BRIDGER MANAGEMENT, LLC | 3,791,531 | $15,545,000 | 1.30% |
| Avoro Capital Advisors LLC | 4,750,000 | $19,475,000 | 1.16% |
| Opaleye Management Inc. | 550,000 | $2,255,000 | 0.84% |
| CREDIT AGRICOLE S A | 1,307,428 | $5,360,000 | 0.30% |
| Eversept Partners, LP | 65,000 | $266,500 | 0.14% |
| HIGHLAND CAPITAL MANAGEMENT LP | 453,360 | $1,859,000 | 0.14% |
| 683 Capital Management, LLC | 500,000 | $2,050,000 | 0.12% |
| Artal Group S.A. | 400,000 | $1,640,000 | 0.06% |